INTRODUCTION
A substance with chemotactic properties for polymorphonuclear neutrophils appears in their lysosomal fraction after phagocytosis of microcrystalline monosodium urate crystals. Previous studies indicate that the appearance of factor activity is abolished by preincubation of the cells with inhibitors of protein synthesis (1, 2) . The purpose of the present study was to isolate and to characterize the factor. METHODS Isolation and molecular weight deteritnation of urate induced cheniotactic factor. The factor was extracted from human and from rabbit neutrophils. Human neutrophils were obtained from the peripheral blood by a procedure that utilized Ficoll-Hypaque centrifugation followed by dextran sedimentation (3) . The final cell preparation was 90%o neutrophils, the contaminating cells being mainly erythrocytes. The rabbit cells were obtained from their peritoneum Received for publication 14 January 1976 and in revised form 9 June 1976. as described by Cohn and Hirsh (4) and were 95% neutrophils. The chemotactic factor was prepared as follows: approximately 60 x 106 cells were incubated at 37°C for 45 min in 5 ml of Hanks solution with 6 mg of synthetic monosodium urate crystals (1) made pyrogen free by heating for 1 h at 200°C. The cells were then disrupted, and the lysosomal fraction was obtained by differential centrifugation as previously described (2) . The lysosomal fraction of the cell was disrupted by ultrasonication for 45 s (MSE Mullar Ultrasonic Disintegrator, model 60 W, London, England) on ice and centrifuged at 20,000 g for 20 min in a Beckman model L Ultracentrifuge (Beckman Instruments, Inc., Palo Alto, Calif.), and the supernate (lysosomal extract) was saved. The specific activity for f8 glucuronidase was found to have increased by 6.9-fold in the lysosomal extract and the specific activity of 8 galactosidase by 8-fold as compared to the activity in the whole cell lysate which was disrupted by sonication in 0.1% Triton x 100 (Sigma Chemical Co., St. Louis, Mo.). The total yield for both enzymes was greater than 85%. The specific activity of the chemotactic factor was increased by sixfold in the lysosomal fraction as measured by the Boyden Chamber technique. The lysosomal extract was passed over a 63 x 1.5 cm G-50 Sephadex column (Sigma Chemical Co.), in isotonic saline solution, and the fractions were tested for chemotactic activity. The fractions containing activity were pooled and repassed over the same column. The preparation of the nonchemotactic control followed the same procedure but the cells were killed by freezing before incubation with the crystals. The substances used as molecular weight standards were as follows: bovine parathyroid hormone labeled with 'I, mol wt 9,000 (courtesy of Dr. E. Slatopolsky), porcine insulin, mol wt 6,000 (E. R. Squibb and Sons, New York) and porcine ACTH, mol wt 3,500 (Parke-Davis and Co., Detroit, Mich.). The column fractions were measured for 'I PTH with the aid of a gamma counter (Baird Atomic, Inc., Bedford, Mass., model 707). The column fractions containing the bulk of the insulin and ACTH were determined by optical absorbance. The chemotactically active fraction (3 ml) from several experiments were pooled, dialyzed against deionized water, lyophilized, and run (50 ,ug) (2, (10) (11) (12) . Human and rabbit neutrophils were obtained as described above. Rabbit mononuclear cells were obtained from the peritoneum of rabbits after intraperitoneal injection of sterile mineral oil (13, 14) . Approximately (17) . At the end of the incubation period, the media was removed and centrifuged in the cold for 10 min at 1,300 g, anid the supernate assayed was for LDH and p glucuronidlase as (lescribed. The total activity of the enzymes was measured in separate tubes containing 1 X 107 neutrop)hils in 2 ml of the Hanks solution after cell lysis with 0.1% Triton X 100 (17) . The results are expressed as the p)ercent-SE of the total enzyme activity. In a separate set of experiments, the human neutrophils were incubated in media containing cytochalasin B (Calbiochem, San Diego, Calif.) 5 ug/ml, dissolved in 0.885%o dimethyl sulfoxide in saline (Nutritional Biochemical Co., Cleveland, Ohio) for 10 mni at 370 C. The chemotactic factor, 50 or 100 jug/ml, was subsequently added, and the experiment wvas performed as described above. Additional enzyme assays were performed onlcell homogenates in the presence of 300 ug/ml of chemotactic factor. The presence of cliemotactic factor at this concentration did not affect the activity of either 13-glucuronidase tivity was observed when the chromatographic fractions of the control were tested in the Boyden Chamber. The chemotactically active fraction gave a strong single line in polyacrylamide gel electrophoresis after carbohydrate or protein staining. The line was present at 2.7 cm from the cathode. Two slow migrating lines that stained weakly for protein but not for carbohydrate, were also observed at 1.05 and 1.07 cm from the cathode. Unstained gels were divided into several slices, and their contents were eluted and tested for chemotactic activity. The activity was confined to the gel slice corresponding to the carbohydrate and protein line seen in the stained gels. All subsequent studies were performed by utilizing the eluate of gel slices containing the single chemotactic line.
The purified human chemotactic factor was found to have a carbohydrate content of 3.2% of its dry weight.
The yield of the chemotactic factor was about 15-20 Ag dry weight/100 million cells in five consecutive experiments.
Attraction of neutrophils and mononuclear cells. The chemotactic factor obtained from human cells was observed to attract human neutrophils in a dose-dependent fashion from 1.5 to 50 Ag/ml. At higher concentrations the response reached a plateau (Fig. 1) . The chemotactic factor was also seen to attract mononuclear cells but to a much lesser extent than neutrophils (Fig. 1) .
The chemotactic factor obtained from human neutrophils attracted rabbit and human cells to a similar degree. Likewise, the factor obtained from rabbit cells was equally effective in attracting human or rabbit cells (Table I) .
Suppression of the chemotactic response. Human neutrophils were incubated with the urate induced chemotactic factor or complement activated plasma, and the ability of the cells to respond chemotactically to either factor was evaluated. The chemotactic response of neutrophils preincubated with human urate induced chemotactic factor and then challenged in the chemotactic chamber with the same chemotactic factor was inhibited. The degree of inhibition was related to the concentration of chemotactic factor used in the preincubation. Inhibition was again seen when complement activated plasma was used as the chemotactic challenge (Table II) . When the cells were preincubated with activated plasma and in the chemotactic chamber, challenged with complement activated plasma or urate induced chemotactic factor, an inhibition in the ability of the cells to migrate was again observed (Table II) .
Ability of the chcmtotactic factor to induce lysosornal enzyme release. When human neutrophils were incubated with the chemotactic factor at various concentrations from 50 to 500 Ag/ml no increase of P glucuronidase release above control levels was observed. Likewise, the activity of the cytoplasmic enzyme LDH was not significantly different in the control media than in the media of samples incubated with the chemotactic factor (Table III) . When the lysosomal enzyme release was measured in the presence of cytochalasin B and the chemotactic factor (100 Ag/ml), a significant release of P glucuronidase but not LDH above control levels was observed. Cytochalasin B used at a concenitration of 5 ,g/ml.
Pair analysis between samples containiing cytochalasin B and 100,g of chemotactic factor vs. samples with cytochalasin B but not chemotactic factor was statistically significant (<0.025). * Dry weight.
$ Phenolphthalein 24 h/107 nieutrophils.
Heat sensitivity. The chemotactic activity of the factor was abolished by heating it at 80°C for 30 min.
DISCUSSION
The interaction of neutrophils with urate crystals leads after phagocytosis of the crystals to the appearance of a chemotactic factor in the lysosomal fraction of the cell (1. 2). Previous studies have suggested that the appearance of factor activitv is due to the induction of new protein synthesis (1) . The current experiments show that the human urate induced chemotactic factor is a glycoprotein with a mol wt of approximately 8.400 daltons. It has the ability to attract human as well as rabbit neutrophils and, to a lesser degree, rabbit mononuclear cells; likewise, rabbit urate induced chemotactic factor can attract human and rabbit neutrophils and rabbit mononuclear cells to a lesser degree. The chemotactic factor dose-response curve for neutrophils and mononuclear cells was observed to reach a broad plateau with increasing concentration of the chemotactic factor. Similar dose response curves for other chemotactic factors have been described (19) (20) (21) . Comparison of the chemotactic activity for neutrophils between urate induced chemotactic factor and C5a. as reported by Gallin et al. (22) . stuggest that the urate induced chemotactic factor is less active on a molar basis. The (17) . The concentration of the urate induced chemotactic factor that produced a onefold increase of f glucuronidase release above control levels from cytochalasin B treated cells was approximately 10 times greater than the corresponding concentration required to elicit an equivalent degree of chemotaxis. This is about twice the corresponding relationship between the ability of C5a to elicit /3 glucuronidase release from cytochalasin B treated cells (23) and chemotaxis from human granulocytes (22) .
The preincubation of human neutrophils with complement activated plasma or human urate induced chemotactic factor was shown to prevent the human neutrophils from migrating towards a chemotactic gradient when, after washing, the cells were challenged with either of the factors in the Boyden Chamber. The chemotactic activity of complement activated plasma has been show1N-n to be due mainly to C5a and C567 (17) . The inhiibition of the PMNs chemotactic response by preincubation of the cells with the same chemotactic factor has been calle(d deactivation bv Ward and Becker (18) .
Cross-deactivation between the chemotactic factors C5a and kallikrein (24) and between different complement derived chemotactic factors (25) has been described.
Cross-deactivation of PMNs is consistent with a concept that chemotactic factors share a general recognition site(s) on the sturface of the cell which can be saturated with chemotactic factor. thus preventing the recognition of a chemotactic gradient. Alternatively, different recognition sites may exist which, when bound to chemotactic factors. lead to the activation of a common pathw\'ay; once fully activated, the cell would be prohibited from responding withl directional migration to another chemotactic factor which it is, however, capable of recognizing.
In conclusion, the described cell derived glycoprotein Possesses several of the characteristics of other reported chelliotactic factors for neutrophils stuch as chemoattraction of neutrophils and mononuclear cells, cross-deactivation of netutrophils, and the ability to induce lysosomal enzynme release from cytochalasin B treated cells.
